Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Reset Pharmaceuticals logo — Advancing Novel Psychedelic Medicines to Improve Mental Heal...

Reset Pharmaceuticals

Advancing Novel Psychedelic Medicines to Improve Mental Health in Persons with Life-threatening Illness

Founded 2020 2 employees Series A Total: $11.10M Biotechnology, Health Care

General Information

Company Name Reset Pharmaceuticals
Founded Year 2020
Employees 2
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when Reset Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Reset Pharmaceuticals

Reset Pharmaceuticals is a biotechnology startup founded in 2020, dedicated to advancing novel psychedelic medicines to improve mental health in individuals with life-threatening illnesses, particularly cancer. The company's lead program revolves around psilocybin in conjunction with psychotherapy, aiming to address demoralization, anxiety, and depression in cancer patients. Reset Pharma has garnered significant support, having secured a $11.10M Series A investment on 16 February 2022, with key participation from Negev Capital, PsyMed Ventures, and Ayuh Ventures. The company has positioned itself with a highly experienced biotech development team and boasts a Scientific Advisory Board comprising leading experts in psychiatry, oncology, and psychedelics. Reset Pharmaceuticals operates at the intersection of biotechnology and healthcare, pioneering innovative approaches to address critical mental health needs in individuals facing life-threatening illnesses.

Taxonomy: Pharmaceuticals, Psychedelic Medicine, Mental Health, Cancer Treatment, Drug Development, Psychotherapy, Medical Research, Life-Threatening Illness, Psilocybin, Demoralization, Anxiety, Depression, Scientific Advisory Board, Oncology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor Investor Investor
16 Feb 2022

Reset Pharmaceuticals Alternatives & Competitors

Reset Pharmaceuticals vs
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Netherlands B.V.

Empowering hope in blood cancer treatment with innovative therapies to meet high-unmet medical needs...

Post Ipo Equity
2 employees
Biopharma, Biotechnology
Reset Pharmaceuticals vs
Reset
Reset United States

We were founded on one simple premise: patients with chronic kidney disease deserve better.

Seed
3 employees
Health Care
Reset Pharmaceuticals vs
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology United States

is part of Sumitomo Pharma America as of July 2023

49 employees
Health Care, Health and Wellness

FAQ About Reset Pharmaceuticals

Advancing Novel Psychedelic Medicines to Improve Mental Health in Persons with Life-threatening Illness
Reset Pharmaceuticals was founded in 2020.
Reset Pharmaceuticals operates in the following industries: Biotechnology, Health Care.
Reset Pharmaceuticals has approximately 2 employees.
Reset Pharmaceuticals has completed 1 funding round, raising a total of $11.10M. The latest funding stage is Series A.
Top alternatives and competitors to Reset Pharmaceuticals include Kiadis Pharma Netherlands B.V., Reset, Sumitomo Pharma Oncology, LeadInvent Pharma Inc., MaaT Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reset Pharmaceuticals and Kiadis Pharma Netherlands B.V. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Reset Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes